Research Activities

Obesity and metabolic disease
Our research focuses on metabolic disease related to endocrine disturbances, including obesity, and diabetes mellitus. Animal models are useful to physiological and pathological conditions for understanding clinical issues in humans. Our research interests are focused on the effects of bioactive compounds for adjunctive therapy of diabetes mellitus which provide the important knowledge of long-term management in patients. Additionally, we study the mechanisms associating with insulin resistance in diet-induced obesity (DIO) rat models.

: B513A

Receptor pharmacology, signal transduction, medicinal plant, endocrine/immunopharmacology

Current research of this laboratory focus on the functions of estrogen receptors on immune cells and the roles of estrogen in autoimmune diseases, the activities are also compared with phytoestrogens, a potential alternative to estrogens. This work includes the search for the mechanisms of signaling pathways and how these signaling pathways relate to human diseases.

Room: B513

Staff: Assoc. Prof. Darawan Pinthong

Laboratory for neuroprotective aspects of Thai medicinal plants

Our lab is interested in the neuroprotective aspects of Thai medicinal plants, such as Curcuma longa, Curcuma comosa, and Moringa oleifera, these are known to have anti-oxidant and anti-inflammatory properties. Oxidative stress and neuroinflammation resulting from chronic activation of microglia have been implicated in the pathogenesis of neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. Two in vitro models of neurodegeneration are studied in the lab: the first model uses a neurotoxin specific to dopaminergic neurons to induce neurotoxicity in dopaminergic cell lines; the second model uses lipopolysaccharide (LPS) to induce microglial activation. Our current focus is on identifying signaling pathways involved in the neuroprotective effects of the crude extracts and pure compounds isolated from the medicinal plants. In the future, we will expand our studies of neurodegenerative diseases to incorporate advanced molecular biology techniques and topics, such as microarray profiling, RNA interference, lentiviral vector expression, and stem cell therapeutics.

Room: B509

Staff: Asst. Prof. Pimtip Sanvarinda, Assoc. Prof. Nattinee Jantaratnotai

Laboratory for iron and free radical research

Free radical reactions involve in pathogenesis of several diseases. Our laboratory develops and utilizes the advance technique especially electron paramagnetic resonance (EPR) spectroscopy to characterize free radical reactions mainly in iron overload and thalassemia syndrome as well as other oxidative related diseases. Pharmacology of iron chelators is also a line of our research.

Room: B507

Staff: Assoc. Prof. Noppawan Phumala Morales

Laboratory of animal models in pain research and musculoskeletal disorders

Our research focuses on using animal models as research tools to provide important knowledge of pathological conditions that can eventually lead to the development of more effective clinical treatment of musculoskeletal disorders in humans. The animal models are essential to bridge the translational gap between in vitro studies and clinical research. Our research interests are focused on identifying alternative approaches for treating pain-associated with orthopaedic conditions such as osteoarthritis and cartilage injuries. We currently employed tissue engineering approaches such as mesenchymal stem cell therapies and synthetic scaffold implantation to repair damaged cartilage and bone in a rat model of cartilage and bone defect. In addition, mechanisms underlying musculoskeletal pain are also of interest.

Room: Pr503

Staff: Assoc. Prof. Ruedee Hemstapat

Thrombosis and hemostasis research

My laboratory is primarily focusing on thrombosis and hemostasis research. With a strong collaboration with Faculty of Medicine Ramathibodi Hospital, I am doing a pilot study about characterization of the biochemistry and coagulant activity of recombinant human factor VIIa produced from a novel hepatocyte-like cell derived from mesenchymal stem cells.

Room: Pr505

Staff: Dr. Pansakorn Tanratana

Laboratory for neuropharmacology & pharmacology of medicinal plants

Our research interests are the neuroprotective and anticancer effects of medicinal plants. Current research is focus on the studying the underlying mechanisms of the neuroprotective and anticancer activities of the crude extracts and pure compounds extracted from the medicinal plants. In addition, the molecular modeling and computer aided drug design are carried out to study the antiaging and anticancer compounds isolated from natural products.

Room: Pr511

Staff: Dr. Somchai  Yanarojana

Anticancer drug discovery
Our lab focuses on the discovery of novel anticancer agents derived from medicinal plants and modified analogs. We also focus on the identification of drug targets that can effectively treat gastrointestinal (GI) cancers, the third most deadly human malignancies. Moreover, we also establish tumor xenograft models for testing anticancer drugs and understanding the treatment responses

: Pr 515

Drug/xenobiotic metabolism and pharmacogenetics

The current research is now focusing on drug and xenobiotic metabolism both in vitro and in vivo (human) and developing in vitro-in vivo extrapolation approach. The study includes characterization the impact of drug-drug and drug-herb interactions on drug safety and efficacy. The research also focuses on the studying genetic polymorphisms of drug-metabolizing enzymes and other genes that influence drug response and toxicity.  

Room: Pr521
StaffDr. Porntipa Korprasertthaworn